Compare · DHR vs NVOS
DHR vs NVOS
Side-by-side comparison of Danaher Corporation (DHR) and Novo Integrated Sciences Inc. (NVOS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and NVOS operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $134.62B, about 3846.1x NVOS ($35.0M).
- Over the past year, DHR is down 5.7% and NVOS is up 0.0% - NVOS leads by 5.7 points.
- DHR has hit the wire 6 times in the past 4 weeks while NVOS has been quiet.
- DHR has more recent analyst coverage (25 ratings vs 0 for NVOS).
- Company
- Danaher Corporation
- Novo Integrated Sciences Inc.
- Price
- $191.49-0.47%
- $0.15-17.66%
- Market cap
- $134.62B
- $35.0M
- 1M return
- +1.42%
- +0.00%
- 1Y return
- -5.66%
- +0.00%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 6
- 0
- Recent ratings
- 25
- 0
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Novo Integrated Sciences Inc.
Novo Integrated Sciences, Inc., together with its subsidiaries, provides primary healthcare services. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers specialty treatment and recovery programs derived from motor vehicle accident injuries, long-term disability cases, corporate wellness, and job-site injuries. Further, it provides cold laser therapeutics, shockwave therapy, custom bracing and orthotics, custom compression therapy/stockings, and lymphatic drainage treatment. The company offers medical technology services, such as telemedicine and remote patient monitoring. It operates 16 owned clinics, a contracted network of 102 affiliate clinics, and 220 eldercare related care homes, as well as retirement homes and community-based locations in Canada. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.
Latest DHR
- Danaher Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Danaher Reports Second Quarter 2026 Results
- VP, Chief Accounting Officer Bouda Christopher covered exercise/tax liability with 60 shares, decreasing direct ownership by 0.65% to 9,107 units (SEC Form 4)
- Director Filler Linda exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 9% to 26,829 units (SEC Form 4)
- Director Zerhouni Elias A. exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 5% to 45,303 units (SEC Form 4)
- Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems
- Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa
- Danaher Schedules Second Quarter 2026 Earnings Conference Call
- Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
- SEC Form 11-K filed by Danaher Corporation
Latest NVOS
- SEC Form SEC STAFF ACTION filed by Novo Integrated Sciences Inc.
- Novo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update
- Novo Integrated Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Novo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update
- Novo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update
- Novo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update
- Novo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update
- SEC Form NT 10-Q filed by Novo Integrated Sciences Inc.
- SEC Form 10-K filed by Novo Integrated Sciences Inc.
- Novo Integrated Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits